archiveTakeda

In a move that highlights the growing role of artificial intelligence in healthcare, U.S.-based biotechnology firm Nabla Bio has announced an expansion of its collaboration with Japan’s Takeda Pharmaceutical Company. This partnership aims to speed up the discovery and development of protein-based therapeutics using AI, potentially transforming the way new...

A key development set to change the pharmaceutical research landscape occurred this morning, with Bristol Myers Squibb (BMS) and Takeda Pharmaceuticals announcing plans to share their respective proprietary data to facilitate AI-based drug discovery. This partnership, announced on October 1, 2025, aims to leverage the power of AI to accelerate...